Price (delayed)
$14.275
Market cap
$336.9M
P/E Ratio
11.51
Dividend/share
N/A
EPS
$1.24
Enterprise value
$326.24M
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical's Mission is to help
There are no recent dividends present for TCMD.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.